TrialBMC pulmonary medicine2026

Effect of MN-166 (ibudilast) on acute respiratory failure prevention in hospitalized participants with COVID-19: a randomized, double-blind, placebo-controlled phase 2 study.

David L Wyles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.